Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NYAP1 (neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 1) is a neuron-specific adaptor protein encoded by a gene located on chromosome 7[1][2]. NYAP1 mediates tyrosine kinase signaling in developing neurons by being phosphorylated (notably by Fyn kinase) in response to upstream signals such as Contactin5[3][4]. Tyrosine-phosphorylated NYAP1 interacts directly with the regulatory subunit p85 of phosphoinositide 3-kinase (PI3K), activating the PI3K/Akt/Rac1 signaling axis. Simultaneously, NYAP1 participates in linking this pathway with the WAVE1 protein complex, which regulates actin cytoskeleton remodeling necessary for neuronal morphogenesis[1][3]. Functional studies in mice show that disruption of NYAP1 and its family members impairs neurite elongation, neuronal migration, and leads to reduced brain size, emphasizing its role in brain development[3][4]. NYAP1 does not belong to canonical therapeutic target classes such as receptors or enzymes but serves as a critical signaling adaptor in neurons. There are no approved or investigational drugs that directly target NYAP1, nor is it currently used as a clinical biomarker[5]. Genetic association studies indicate that the NYAP1 locus may be implicated in neurodevelopmental disorders such as autism, but clinical significance remains to be fully established[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 1 (NYAP1).